DISSECTION P325 - ESOC25-1819 INTERNATIONAL INTRACRANIAL DISSECTION STUDY (I-IDIS): DEMOGRAPHICS, RISK FACTORS AND CLINICAL CHARACTERISTIC OF 110 PATIENTS Barbara Birner 1 , Elias Auer 1 , Christina Leistner 2 , Hakan Sarikaya 2 , David Seiffge 2 , Barbara Goeggel Simonetti 2 , Masatoshi Koga 3 , Stephanie Debette 4 , Michelangelo Mancuso 5 , Stefan Engelter 6 , Christopher Trnka 6 , Jukka Putaala 7 , Marcel Arnold 2 , Bastian Volbers 2 1 Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Switzerland., Bern, Switzerland, 2 Department of Neurology, Inselspital, Bern University Hospital, and University of Bern, Switzerland, Bern, Switzerland, 3 Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan, Suita, Japan, 4 Department of Neurology, Institute for Neurodegenerative Diseases, CHU de Bordeaux, Bordeaux, France., Bordeaux, France, 5 Department of Clinical and Experimental Medicine, Neurology Unit, University of Pisa, Pisa, Italy, Pisa, Italy, 6 Stroke Center and Department of Neurology, University Hospital Basel and University of Basel, Basel, Switzerland, Basel, Switzerland, 7 Department of Neurology Helsinki University Hospital and University of Helsinki Finland, Helsinki, Finland Background and Aims: While knowledge of extracranial cervical artery dissection (CeAD) has increased based on large clinical studies, knowledge on intracranial artery dissection (IAD) is limited
Although typically found in the caveolae of plasma membranes, proteomic analysis has demonstrated that in adipocytes caveolin-1 localizes to the lipid droplet as well (14, 23, 93, 103)
Information technology companies are subject to certain risks, including rapidly changing technologies, short product life cycles, fierce competition, aggressive pricing and reduced profit margins, loss of patent, copyright and trademark protections, cyclical market patterns, evolving industry standards and regulation and frequent new product introductions
Areas of Scientific Interest Research involving BPC-157 has explored: Cellular signalling pathways Angiogenesis-related mechanisms Connective tissue biology Gastrointestinal research Vascular response systems As with all research compounds, BPC-157 is intended exclusively for laboratory and scientific research purposes
However, the IM route was the top-ranked statistically, followed by the SL and then the oral routes, but without clinical significance
